Edinburgh Partners’s Allergan plc AGN Stock Holding History

Edinburgh Partners’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-468	Closed	-$114K	–	32
2017 Q2	$114K	Hold	468	–	–	0.03%	16
2017 Q1	$112K	Hold	468	–	–	0.03%	18
2016 Q4	$98K	Hold	468	–	–	0.02%	23
2016 Q3	$108K	Hold	468	–	–	0.02%	21
2016 Q2	$108K	Hold	468	–	–	0.02%	22
2016 Q1	$125K	Hold	468	–	–	0.01%	18
2015 Q4	$146K	Hold	468	–	–	0.02%	17
2015 Q3	$127K	Hold	468	–	–	0.01%	15
2015 Q2	$144K	Hold	468	–	–	0.02%	14
2015 Q1	$139K	Hold	468	–	–	0.02%	12
2014 Q4	$121K	Hold	468	–	–	0.01%	13
2014 Q3	$112K	Hold	468	–	–	0.01%	11
2014 Q2	$105K	Hold	468	–	–	0.01%	11
2014 Q1	$96K	Hold	468	–	–	0.01%	10
2013 Q4	$78K	Buy	468 +100	+27%	+$15.6K	0.01%	19
2013 Q3	$53K	Hold	368	–	–	﹤0.01%	26
2013 Q2	$47K	Buy	+368	New	+$41.7K	﹤0.01%	27

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Edinburgh Partners's AGN Position: Q3 2017 in Review

Edinburgh Partners sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 468 shares — an estimated $114K sold.

Edinburgh Partners first reported a position in AGN in Q2 2013 and held it in 17 quarters. The position peaked at $146K in Q4 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

Edinburgh Partners reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
Edinburgh Partners sold 468 Allergan plc shares in Q3 2017, an estimated $114K.
Edinburgh Partners first reported a position in Allergan plc in Q2 2013 and held it in 17 quarters.
Edinburgh Partners's Allergan plc position peaked at $146K in Q4 2015.
1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Edinburgh Partners's 13F filing for Q3 2017, filed 30 Oct 2017.